NCT00564642View on ClinicalTrials.gov

Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

April 30, 2009

Conditions
HepatitisTuberculosis
Interventions
DRUG

N Acetylcysteine

1200 mg, BD, 2weeks

Trial Locations (1)

19556

National Research Institute of Tuberculosis and Lung Disease (NRITLD), Tehran

All Listed Sponsors
lead

National Research Institute of Tuberculosis and Lung Disease, Iran

OTHER_GOV

NCT00564642 - Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity | Biotech Hunter | Biotech Hunter